Identifying ATM inhibitors for potential Huntington’s disease therapeutics: an interview with Perla Breccia
In this interview, Perla Breccia, Team Leader, Chemistry, Charles River (MA, USA), discusses her poster presented at the 19th RSC / SCI Medicinal Chemistry Symposium (10–13 September 2017, Churchill College, Cambridge, UK).
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.